If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


VOLUME 59   1998   SUPPLEMENT 14

Articles

3 Introduction. Reboxetine: A New Selective Antidepressant for the Treatment of Depression. Stuart A. Montgomery, M.D., and Alan F. Schatzberg, M.D.
[PDF]

4 Antidepressant Efficacy and Tolerability of the Selective Norepinephrine Reuptake Inhibitor Reboxetine: A Review. Graham D. Burrows, M.D.; Kay P. Maguire, Ph.D.; and Trevor R. Norman, Ph.D.
[Abstract] [PDF]

8 Reboxetine Versus Fluoxetine: An Overview of Efficacy and Tolerability. Juan Massana, M.D.
[Abstract] [PDF]

11 Monoamine Dysfunction and the Pathophysiology and Treatment of Depression. Dennis S. Charney, M.D.
[Abstract] [PDF]

15 Noradrenergic Versus Serotonergic Antidepressants: Predictors of Treatment Response. Alan F. Schatzberg, M.D.
[Abstract] [PDF]

19 The Measurement of Retardation in Depression. Nicolas Dantchev, M.D., Ph.D., and Daniel J. Widlöcher, M.D.
[Abstract] [PDF]

26 Chairman’s Overview: The Place of Reboxetine in Antidepressant Therapy. Stuart A. Montgomery, M.D.
[PDF]